Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions

Clinical trial NCT01862900 · COMPLETED

Trial details

NCT number: NCT01862900
Sponsor: Providence Health & Services
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Lung Metastases Liver Metastases

Start date: 2012-04-27
Primary completion: 2016-05-17
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.